Go Pro

Darling Ingredients (DAR) Financials

Darling Ingredients logo
$69.23 +2.29 (+3.42%)
As of 11:04 AM Eastern
Annual Income Statements for Darling Ingredients

Annual Income Statements for Darling Ingredients

This table shows Darling Ingredients' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Income / (Loss) Attributable to Common Shareholders
79 102 128 101 313 297 651 738 648 279 63
Consolidated Net Income / (Loss)
85 107 133 106 321 300 657 747 660 286 70
Net Income / (Loss) Continuing Operations
85 107 133 106 321 300 657 747 660 286 70
Total Pre-Tax Income
99 123 64 118 380 354 821 894 720 248 61
Total Operating Income
143 155 169 255 476 431 884 1,029 950 468 273
Total Gross Profit
737 757 787 741 775 883 1,242 1,530 1,645 1,278 1,473
Total Revenue
3,391 3,392 3,662 3,388 3,364 3,572 4,741 6,532 6,788 5,715 6,136
Operating Revenue
3,391 3,392 3,662 3,388 3,364 3,572 4,741 6,532 6,788 5,715 6,136
Total Cost of Revenue
2,654 2,635 2,876 2,646 2,589 2,689 3,499 5,003 5,143 4,437 4,662
Operating Cost of Revenue
2,654 2,635 2,876 2,646 2,589 2,689 3,499 5,003 5,143 4,437 4,662
Total Operating Expenses
595 602 617 486 299 452 358 501 695 810 1,200
Selling, General & Admin Expense
316 312 344 309 359 378 392 437 543 492 551
Depreciation Expense
270 290 302 321 326 350 316 395 502 504 509
Other Operating Expenses / (Income)
- - -28 -160 -364 -315 -352 -372 -366 -149 49
Restructuring Charge
8.30 0.40 0.00 15 0.00 38 2.17 46 32 14 74
Other Special Charges / (Income)
- - -0.24 0.71 -21 0.43 -0.96 -4.49 -15 -51 18
Total Other Income / (Expense), net
-44 -32 -105 -137 -95 -77 -63 -135 -230 -221 -212
Interest Expense
106 94 89 110 91 73 62 126 259 254 225
Interest & Investment Income
73 70 0.27 -0.55 0.43 3.19 5.75 5.10 5.01 12 13
Other Income / (Expense), net
-12 -8.39 -17 -27 -5.02 -7.82 -6.75 -15 24 21 0.08
Income Tax Expense
14 15 -69 12 59 53 164 147 60 -38 -9.36
Net Income / (Loss) Attributable to Noncontrolling Interest
6.75 4.91 4.89 4.45 8.37 3.51 6.38 9.40 13 6.97 7.58
Basic Earnings per Share
$0.48 $0.62 $0.78 $0.62 $1.90 $1.83 $4.01 $4.58 $4.05 $1.75 $0.40
Weighted Average Basic Shares Outstanding
165.03M 164.60M 164.75M 164.79M 163.92M 162.60M 161.10M 159.95M 159.61M 158.87M 158.60M
Diluted Earnings per Share
$0.48 $0.62 $0.77 $0.60 $1.86 $1.78 $3.90 $4.49 $3.99 $1.73 $0.39
Weighted Average Diluted Shares Outstanding
165.03M 164.60M 164.75M 164.79M 163.92M 162.60M 161.10M 159.95M 159.61M 158.87M 158.60M
Weighted Average Basic & Diluted Shares Outstanding
165.03M 164.60M 164.75M 164.79M 163.92M 162.60M 161.10M 159.95M 159.61M 158.87M 158.60M

Quarterly Income Statements for Darling Ingredients

This table shows Darling Ingredients' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026 7/4/2026
Net Income / (Loss) Attributable to Common Shareholders
85 81 79 17 102 -26 13 19 57 134 387
Consolidated Net Income / (Loss)
87 82 81 19 104 -24 14 21 59 137 389
Net Income / (Loss) Continuing Operations
87 82 81 19 104 -24 14 21 59 137 389
Total Pre-Tax Income
95 85 82 1.64 78 -25 18 20 48 176 500
Total Operating Income
159 137 149 60 122 28 76 72 97 227 555
Total Gross Profit
436 304 327 314 334 311 346 387 429 405 503
Total Revenue
1,614 1,420 1,455 1,422 1,418 1,381 1,482 1,564 1,710 1,551 1,724
Operating Revenue
1,614 1,420 1,455 1,422 1,418 1,381 1,482 1,564 1,710 1,551 1,724
Total Cost of Revenue
1,178 1,117 1,128 1,108 1,084 1,069 1,136 1,177 1,281 1,146 1,221
Operating Cost of Revenue
1,178 1,117 1,128 1,108 1,084 1,069 1,136 1,177 1,281 1,146 1,221
Total Operating Expenses
278 166 178 253 211 283 270 315 332 178 -52
Selling, General & Admin Expense
133 139 130 116 108 122 138 140 152 149 151
Depreciation Expense
138 128 125 124 128 124 121 124 140 131 130
Other Operating Expenses / (Income)
-4.69 -78 -44 -2.43 -24 31 -6.00 46 -22 -107 -350
Restructuring Charge
15 4.05 1.13 0.22 8.23 1.53 3.38 6.16 63 5.33 17
Other Special Charges / (Income)
-3.12 -26 -33 16 -8.55 5.50 14 -0.38 -0.98 0.20 -0.12
Total Other Income / (Expense), net
-64 -52 -66 -58 -44 -53 -58 -52 -50 -51 -55
Interest Expense
68 63 69 67 55 58 55 57 56 54 56
Interest & Investment Income
1.51 2.31 3.02 3.78 2.89 2.63 2.53 3.28 4.33 2.90 1.91
Other Income / (Expense), net
2.62 8.89 -0.16 4.60 7.82 1.97 -5.21 1.73 1.60 0.13 -1.71
Income Tax Expense
7.25 3.91 0.77 -17 -26 -1.15 4.07 -1.25 -11 39 111
Net Income / (Loss) Attributable to Noncontrolling Interest
2.74 0.43 2.50 2.17 1.87 2.35 1.60 1.69 1.94 2.74 1.96
Basic Earnings per Share
$0.53 $0.51 $0.49 $0.11 $0.64 ($0.16) $0.08 $0.12 $0.36 $0.85 $2.44
Weighted Average Basic Shares Outstanding
159.61M 159.78M 159.02M 159.05M 158.87M 158.16M 158.19M 158.19M 158.60M 158.93M 157.80M
Diluted Earnings per Share
$0.53 $0.50 $0.49 $0.11 $0.63 ($0.16) $0.08 $0.12 $0.35 $0.83 $2.41
Weighted Average Diluted Shares Outstanding
159.61M 159.78M 159.02M 159.05M 158.87M 158.16M 158.19M 158.19M 158.60M 158.93M 157.80M
Weighted Average Basic & Diluted Shares Outstanding
159.61M 159.78M 159.02M 159.05M 158.87M 158.16M 158.19M 158.19M 158.60M 158.93M 157.80M

Annual Cash Flow Statements for Darling Ingredients

This table details how cash moves in and out of Darling Ingredients' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Change in Cash & Equivalents
48 -42 -7.94 0.45 -34 8.68 -13 81 114 -47 -14
Net Cash From Operating Activities
421 391 410 399 363 625 704 814 899 839 1,060
Net Cash From Continuing Operating Activities
421 391 410 399 363 625 704 814 899 839 1,060
Net Income / (Loss) Continuing Operations
85 107 133 106 321 300 657 747 660 286 70
Consolidated Net Income / (Loss)
85 107 133 106 321 300 657 747 660 286 70
Depreciation Expense
270 290 302 321 326 350 316 395 502 504 509
Amortization Expense
10 11 8.74 7.87 5.85 5.36 4.04 4.98 6.22 5.62 5.50
Non-Cash Adjustments To Reconcile Net Income
8.09 -16 0.82 -32 -325 -65 -404 -362 -136 185 514
Changes in Operating Assets and Liabilities, net
48 -0.83 -35 -4.71 35 34 130 29 -133 -141 -39
Net Cash From Investing Activities
-230 -243 -284 -342 -338 -311 -490 -2,417 -1,675 -499 -681
Net Cash From Continuing Investing Activities
-230 -243 -284 -342 -338 -311 -490 -2,417 -1,675 -499 -681
Purchase of Property, Plant & Equipment
-230 -244 -274 -322 -359 -280 -274 -391 -555 -332 -380
Acquisitions
-4.22 -8.53 -19 -112 -5.08 -34 -191 -2,039 -1,170 -207 -328
Other Investing Activities, net
4.40 8.87 14 21 23 3.09 -25 13 50 40 27
Net Cash From Financing Activities
-140 -184 -155 -48 -55 -307 -221 1,679 876 -400 -377
Net Cash From Continuing Financing Activities
-140 -184 -155 -48 -55 -307 -221 1,679 880 -400 -377
Repayment of Debt
-795 -312 -362 -696 -1,011 -755 -665 -1,953 -2,524 -1,790 -3,256
Repurchase of Common Equity
-5.91 -5.00 0.00 0.00 -19 -55 -168 -126 -53 -34 -35
Payment of Dividends
-3.38 -1.55 -23 -10 -6.53 -6.25 -6.02 -4.53 -9.08 -11 -5.37
Issuance of Debt
669 137 233 1,172 987 530 664 3,809 3,483 1,443 3,057
Issuance of Common Equity
0.17 0.19 0.02 0.18 0.04 0.07 0.05 0.00 0.00 0.45 3.66
Other Financing Activities, net
-4.87 -1.84 -3.05 -513 -4.47 -21 -47 -47 -17 -8.14 -141
Effect of Exchange Rate Changes
-3.60 -6.30 21 -8.17 -3.99 1.64 -5.45 5.30 14 12 -15

Quarterly Cash Flow Statements for Darling Ingredients

This table details how cash moves in and out of Darling Ingredients' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026 7/4/2026
Net Change in Cash & Equivalents
11 28 -27 -4.65 -44 6.86 -5.45 -15 -0.65 25 37
Net Cash From Operating Activities
217 264 147 274 154 249 146 224 441 153 533
Net Cash From Continuing Operating Activities
217 264 147 274 154 249 146 224 441 153 533
Net Income / (Loss) Continuing Operations
87 82 81 19 104 -24 14 21 59 137 389
Consolidated Net Income / (Loss)
87 82 81 19 104 -24 14 21 59 137 389
Depreciation Expense
138 128 125 124 128 124 121 124 140 131 130
Amortization Expense
1.54 1.40 1.40 1.42 1.42 1.43 1.46 0.95 1.67 1.30 1.30
Non-Cash Adjustments To Reconcile Net Income
69 1.42 11 139 34 144 27 29 314 -157 -102
Changes in Operating Assets and Liabilities, net
-79 52 -72 -8.33 -113 3.69 -18 50 -74 41 114
Net Cash From Investing Activities
-169 -291 -97 -65 -46 -51 -109 -287 -235 -289 -235
Net Cash From Continuing Investing Activities
-169 -291 -97 -65 -46 -51 -109 -287 -235 -289 -235
Purchase of Property, Plant & Equipment
-175 -94 -98 -67 -73 -63 -71 -90 -156 -95 -129
Acquisitions
-0.00 -200 -6.98 0.20 -0.00 -0.15 -40 -201 -87 -202 -111
Other Investing Activities, net
6.11 2.76 8.24 2.27 27 12 2.26 3.26 9.28 7.69 5.18
Net Cash From Financing Activities
-26 49 -81 -201 -166 -185 -31 47 -208 183 -262
Net Cash From Continuing Financing Activities
-26 49 -81 -201 -166 -185 -31 47 -208 183 -262
Repayment of Debt
-720 -533 -587 -406 -264 -237 -1,861 -570 -587 -135 -378
Repurchase of Common Equity
- 0.00 -29 - -5.08 -35 - - - 0.00 -73
Issuance of Debt
698 588 538 212 105 93 1,857 691 416 340 210
Issuance of Common Equity
- 0.44 - - 0.01 0.34 0.07 3.25 - 2.56 0.09
Other Financing Activities, net
-3.81 -6.91 -0.30 -0.78 -0.16 -6.54 -27 -65 -42 -25 -18
Effect of Exchange Rate Changes
-11 6.47 4.11 -13 15 -6.21 -12 1.41 1.50 -23 0.01

Annual Balance Sheets for Darling Ingredients

This table presents Darling Ingredients' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Total Assets
4,761 4,698 4,958 4,889 5,345 5,613 6,134 9,202 11,061 10,070 10,299
Total Current Assets
932 893 956 898 917 987 1,089 1,638 1,856 1,439 1,553
Cash & Equivalents
157 115 107 107 73 82 69 127 127 76 89
Restricted Cash
0.33 0.29 0.14 0.11 0.11 0.10 0.17 0.32 0.29 38 17
Accounts Receivable
371 388 392 386 406 405 469 677 798 591 643
Inventories, net
345 331 358 341 363 406 457 674 759 577 528
Prepaid Expenses
36 30 38 35 47 48 54 86 106 81 85
Current Deferred & Refundable Income Taxes
12 7.48 4.51 6.46 3.32 3.88 1.08 19 24 35 8.28
Other Current Assets
10 22 57 22 25 42 39 56 43 42 40
Other Current Nonoperating Assets
- - - - - - - - - 0.00 143
Plant, Property, & Equipment, net
1,508 1,516 1,646 1,688 1,802 1,864 1,840 2,462 2,935 2,714 2,796
Total Noncurrent Assets
2,321 2,289 2,356 2,304 2,626 2,763 3,205 5,102 6,270 5,917 5,949
Long-Term Investments
247 293 302 410 689 805 1,349 1,926 2,252 2,264 2,207
Goodwill
1,233 1,226 1,301 1,229 1,223 1,260 1,219 1,970 2,485 2,323 2,459
Intangible Assets
782 712 677 596 526 474 398 865 1,076 898 845
Noncurrent Deferred & Refundable Income Taxes
16 15 14 15 14 17 16 18 18 22 25
Other Noncurrent Operating Assets
42 44 62 53 172 207 222 322 440 410 414
Total Liabilities & Shareholders' Equity
4,761 4,698 4,958 4,889 5,345 5,613 6,134 9,202 11,061 10,070 10,299
Total Liabilities
2,786 2,622 2,631 2,554 2,702 2,659 2,786 5,306 6,367 5,606 5,489
Total Current Liabilities
442 452 559 540 688 675 753 1,068 998 1,044 1,035
Short-Term Debt
45 23 16 7.49 91 28 24 70 61 133 75
Accounts Payable
150 181 217 219 239 255 307 472 426 349 371
Accrued Expenses
240 243 314 309 311 335 351 432 441 489 485
Current Deferred & Payable Income Tax Liabilities
6.68 4.91 12 4.04 8.90 17 32 45 16 9.72 16
Other Current Liabilities
- - - 0.00 38 39 38 49 55 63 62
Other Current Nonoperating Liabilities
- - - - - - - - - 0.00 25
Total Noncurrent Liabilities
2,344 2,170 2,071 2,013 2,014 1,984 2,033 4,237 5,369 4,563 4,455
Long-Term Debt
1,886 1,728 1,698 1,667 1,558 1,481 1,439 3,315 4,366 3,909 3,862
Noncurrent Deferred & Payable Income Tax Liabilities
361 346 267 231 248 276 363 482 498 293 241
Other Noncurrent Operating Liabilities
98 96 106 115 207 227 231 441 505 361 352
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,975 2,076 2,328 2,336 2,643 2,954 3,348 3,896 4,694 4,464 4,810
Total Preferred & Common Equity
1,871 1,973 2,245 2,273 2,566 2,892 3,281 3,809 4,605 4,378 4,737
Total Common Equity
1,871 1,973 2,245 2,273 2,566 2,892 3,281 3,809 4,605 4,378 4,737
Common Stock
1,490 1,501 1,517 1,538 1,563 1,599 1,630 1,662 1,700 1,723 1,720
Retained Earnings
750 853 981 1,088 1,400 1,697 2,348 3,086 3,733 4,012 4,075
Treasury Stock
-34 -41 -44 -48 -75 -152 -375 -554 -629 -673 -719
Accumulated Other Comprehensive Income / (Loss)
-336 -340 -210 -305 -322 -252 -322 -384 -198 -684 -339
Noncontrolling Interest
104 103 83 63 78 62 67 87 88 86 73

Quarterly Balance Sheets for Darling Ingredients

This table presents Darling Ingredients' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 4/1/2023 7/1/2023 9/30/2023 3/30/2024 6/29/2024 9/28/2024 3/29/2025 6/28/2025 9/27/2025 4/4/2026 7/4/2026
Total Assets
10,861 10,973 10,810 10,943 10,621 10,573 10,032 10,275 10,452 10,641 10,984
Total Current Assets
1,903 1,876 1,843 1,619 1,508 1,497 1,455 1,495 1,503 1,646 1,757
Cash & Equivalents
133 112 119 145 122 115 81 95 91 116 161
Restricted Cash
0.30 0.30 0.30 4.09 26 39 40 28 16 22 18
Accounts Receivable
751 747 736 624 577 577 597 615 621 637 694
Inventories, net
829 825 823 687 628 618 595 605 622 578 605
Prepaid Expenses
109 117 102 98 89 85 90 80 89 97 107
Current Deferred & Refundable Income Taxes
20 23 26 32 34 40 25 24 23 6.98 7.24
Other Current Assets
61 53 38 28 32 24 26 48 40 61 43
Other Current Nonoperating Assets
- - - - - - - - - 128 122
Plant, Property, & Equipment, net
2,713 2,775 2,799 2,910 2,841 2,856 2,739 2,787 2,786 2,786 2,828
Total Noncurrent Assets
6,246 6,323 6,169 6,413 6,272 6,220 5,838 5,993 6,164 6,209 6,398
Long-Term Investments
2,125 2,214 2,164 2,379 2,416 2,332 2,112 2,162 2,325 2,445 2,586
Goodwill
2,588 2,566 2,447 2,498 2,418 2,456 2,389 2,478 2,499 2,488 2,554
Intangible Assets
1,091 1,075 1,091 1,057 993 977 898 899 881 832 822
Noncurrent Deferred & Refundable Income Taxes
21 25 25 17 17 19 18 16 16 28 21
Other Noncurrent Operating Assets
421 443 441 462 429 436 421 438 442 416 415
Total Liabilities & Shareholders' Equity
10,861 10,973 10,810 10,943 10,621 10,573 10,032 10,275 10,452 10,641 10,984
Total Liabilities
6,740 6,523 6,343 6,260 6,078 5,938 5,496 5,582 5,683 5,697 5,678
Total Current Liabilities
1,099 1,014 1,034 967 963 1,063 1,036 997 1,010 1,040 1,123
Short-Term Debt
119 88 74 103 92 114 117 52 77 75 97
Accounts Payable
434 427 395 343 350 332 348 366 375 356 413
Accrued Expenses
463 420 494 450 450 542 492 498 475 505 504
Current Deferred & Payable Income Tax Liabilities
38 30 18 12 13 15 15 15 16 18 23
Other Current Liabilities
45 48 52 59 58 60 64 67 67 63 64
Other Current Nonoperating Liabilities
- - - - - - - - - 23 21
Total Noncurrent Liabilities
5,641 5,509 5,310 5,292 5,115 4,876 4,461 4,585 4,673 4,657 4,555
Long-Term Debt
4,559 4,459 4,338 4,363 4,317 4,132 3,805 3,929 4,027 4,051 3,851
Noncurrent Deferred & Payable Income Tax Liabilities
523 562 503 464 401 375 289 283 271 270 366
Other Noncurrent Operating Liabilities
559 488 469 465 397 369 366 373 376 336 337
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,122 4,451 4,467 4,683 4,543 4,634 4,536 4,693 4,769 4,944 5,306
Total Preferred & Common Equity
4,033 4,368 4,381 4,593 4,461 4,551 4,448 4,613 4,689 4,876 5,246
Total Common Equity
4,033 4,368 4,381 4,593 4,461 4,551 4,448 4,613 4,689 4,876 5,246
Common Stock
1,675 1,682 1,693 1,714 1,725 1,726 1,725 1,730 1,735 1,735 1,744
Retained Earnings
3,271 3,524 3,649 3,814 3,893 3,910 3,986 3,999 4,018 4,209 4,597
Treasury Stock
-615 -625 -629 -637 -667 -667 -719 -719 -719 -746 -820
Accumulated Other Comprehensive Income / (Loss)
-299 -213 -332 -298 -491 -418 -544 -396 -345 -322 -275
Noncontrolling Interest
89 82 86 90 82 83 87 80 80 68 61

Annual Metrics And Ratios for Darling Ingredients

This table displays calculated financial ratios and metrics derived from Darling Ingredients' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
DEI Shares Outstanding
- - - - - - - - - - 158,186,082.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 158,186,082.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.40
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
123 135 352 229 401 366 708 860 871 541 315
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 11.81% 9.55% 6.36% 3.61%
Earnings before Interest and Taxes (EBIT)
131 146 153 228 471 423 878 1,014 974 489 274
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
411 447 464 558 802 779 1,198 1,414 1,482 999 788
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
514 217 139 369 364 320 891 -974 -644 1,154 128
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,501 3,420 3,633 3,493 3,530 3,576 3,393 5,228 6,742 6,129 6,316
Increase / (Decrease) in Invested Capital
-391 -82 213 -140 38 46 -183 1,835 1,515 -613 187
Book Value per Share
$11.36 $11.99 $13.63 $13.80 $15.67 $17.84 $20.28 $23.77 $28.87 $27.53 $29.95
Tangible Book Value per Share
($0.88) $0.21 $1.62 $2.72 $4.99 $7.15 $10.28 $6.07 $6.55 $7.27 $9.06
Total Capital
3,906 3,827 4,042 4,010 4,293 4,462 4,811 7,281 9,121 8,506 8,747
Total Debt
1,931 1,751 1,714 1,674 1,649 1,508 1,463 3,385 4,427 4,042 3,937
Total Long-Term Debt
1,886 1,728 1,698 1,667 1,558 1,481 1,439 3,315 4,366 3,909 3,862
Net Debt
1,527 1,343 1,305 1,157 887 622 45 1,331 2,049 1,665 1,625
Capital Expenditures (CapEx)
230 244 274 322 359 280 274 391 555 332 380
Debt-free, Cash-free Net Working Capital (DFCFNWC)
378 350 306 258 247 258 292 512 791 415 489
Debt-free Net Working Capital (DFNWC)
535 465 413 365 320 339 361 640 918 529 594
Net Working Capital (NWC)
490 441 397 357 229 312 336 570 858 396 519
Net Nonoperating Expense (NNE)
38 28 219 123 80 66 50 113 211 255 245
Net Nonoperating Obligations (NNO)
1,527 1,343 1,305 1,157 887 622 45 1,331 2,049 1,665 1,507
Total Depreciation and Amortization (D&A)
280 301 311 329 331 356 320 400 508 509 514
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.48 $0.62 $0.78 $0.62 $1.90 $1.83 $4.01 $4.58 $4.05 $1.75 $0.40
Adjusted Weighted Average Basic Shares Outstanding
164.17M 164.71M 164.68M 164.66M 163.92M 162.60M 161.10M 159.95M 159.61M 158.87M 158.60M
Adjusted Diluted Earnings per Share
$0.48 $0.62 $0.77 $0.60 $1.86 $1.78 $3.90 $4.49 $3.99 $1.73 $0.39
Adjusted Weighted Average Diluted Shares Outstanding
164.17M 164.71M 164.68M 164.66M 163.92M 162.60M 161.10M 159.95M 159.61M 158.87M 158.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
164.17M 164.71M 164.68M 164.66M 163.92M 162.60M 161.10M 159.95M 159.61M 158.87M 158.60M
Normalized Net Operating Profit after Tax (NOPAT)
130 136 118 243 384 399 709 895 887 302 256
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Quarterly Metrics And Ratios for Darling Ingredients

This table displays calculated financial ratios and metrics derived from Darling Ingredients' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026 7/4/2026
DEI Shares Outstanding
- - - - - - - - 158,186,082.00 158,603,548.00 158,927,363.00
DEI Adjusted Shares Outstanding
- - - - - - - - 158,186,082.00 158,603,548.00 158,927,363.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.36 0.85 2.44
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-8.71% -20.71% -17.20% -12.51% -12.17% -2.80% 1.80% 9.99% - 12.33% 16.37%
EBITDA Growth
-17.11% -28.51% -43.76% -38.61% -13.65% -43.40% -29.59% 4.64% - 130.74% 254.61%
EBIT Growth
-33.89% -45.30% -59.27% -64.34% -19.32% -79.21% -52.37% 13.52% - 647.11% 683.42%
NOPAT Growth
-27.12% -41.57% -52.18% 244.81% 10.76% -84.81% -59.86% -89.09% - 789.90% 632.27%
Net Income Growth
-45.20% -57.03% -68.12% -85.08% 18.93% -129.19% -82.47% 10.15% - 675.53% 2,628.84%
EPS Growth
-44.21% -56.14% -68.39% -85.71% 18.87% -132.00% -83.67% 9.09% - 618.75% 2,912.50%
Operating Cash Flow Growth
23.77% 40.06% -32.57% -0.77% -28.84% -5.66% -0.49% -18.26% - -38.56% 265.89%
Free Cash Flow Firm Growth
16.25% 101.84% 124.33% 165.21% 156.70% 714.92% -86.31% -96.69% - -95.46% 635.25%
Invested Capital Growth
28.98% 1.22% -4.24% -3.05% -9.10% -5.99% 0.00% 0.73% - 2.54% 0.00%
Revenue Q/Q Growth
-0.68% -12.01% 2.46% -2.30% -0.30% -2.62% 7.31% 5.57% - -9.30% 11.17%
EBITDA Q/Q Growth
-2.61% -8.62% -0.22% -30.86% 36.99% -40.10% 24.12% 2.74% - 49.47% 90.75%
EBIT Q/Q Growth
-11.03% -9.53% 1.57% -56.38% 101.30% -76.68% 132.64% 3.96% - 129.10% 143.95%
NOPAT Q/Q Growth
-27.65% -10.74% 12.38% 375.09% -76.76% -87.76% 197.00% 29.14% - 47.56% 144.39%
Net Income Q/Q Growth
-31.87% -6.50% -0.27% -76.51% 442.91% -122.95% 159.90% 47.60% - 132.78% 184.02%
EPS Q/Q Growth
-31.17% -5.66% -2.00% -77.55% 472.73% -125.40% 150.00% 50.00% - 137.14% 190.36%
Operating Cash Flow Q/Q Growth
-21.55% 21.63% -44.48% 87.33% -43.75% 61.25% -41.43% 53.86% - -65.29% 248.79%
Free Cash Flow Firm Q/Q Growth
0.87% 103.74% 740.92% 109.42% -13.81% -46.31% -85.88% -49.32% - 128.04% 2,185.49%
Invested Capital Q/Q Growth
2.23% -1.80% -3.51% 0.09% -4.15% 1.55% 2.64% 0.81% - 1.04% 0.10%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
27.04% 21.38% 22.46% 22.05% 23.54% 22.55% 23.35% 24.75% - 26.11% 29.20%
EBITDA Margin
18.64% 19.36% 18.85% 13.34% 18.33% 11.27% 13.04% 12.69% - 23.16% 39.73%
Operating Margin
9.84% 9.66% 10.20% 4.23% 8.64% 2.06% 5.12% 4.59% - 14.62% 32.20%
EBIT Margin
10.00% 10.28% 10.19% 4.55% 9.19% 2.20% 4.77% 4.70% - 14.63% 32.11%
Profit (Net Income) Margin
5.41% 5.74% 5.59% 1.34% 7.32% -1.72% 0.96% 1.35% - 8.84% 22.58%
Tax Burden Percent
92.33% 95.43% 99.06% 1,162.71% 132.66% 95.38% 77.82% 106.30% - 78.01% 77.87%
Interest Burden Percent
58.53% 58.53% 55.37% 2.54% 60.06% -82.21% 25.94% 26.96% - 77.43% 90.31%
Effective Tax Rate
7.67% 4.57% 0.94% -1,062.71% -32.66% 0.00% 22.18% -6.30% - 21.99% 22.13%
Return on Invested Capital (ROIC)
10.30% 8.99% 9.47% 44.74% 10.17% 1.27% 3.56% 4.44% - 11.41% 25.70%
ROIC Less NNEP Spread (ROIC-NNEP)
6.79% 6.72% 6.23% 9.77% 7.02% -1.14% 1.03% 1.22% - 8.86% 22.60%
Return on Net Nonoperating Assets (RNNOA)
2.67% 3.33% 2.82% 4.18% 2.84% -0.45% 0.39% 0.45% - 2.92% 6.28%
Return on Equity (ROE)
12.98% 12.31% 12.28% 48.91% 13.02% 0.83% 3.95% 4.89% - 14.34% 31.99%
Cash Return on Invested Capital (CROIC)
-10.75% 10.63% 13.95% 11.03% 17.93% 13.54% 6.94% 5.14% - 4.11% 12.15%
Operating Return on Assets (OROA)
6.70% 6.05% 5.77% 2.52% 4.97% 1.19% 2.60% 2.61% - 8.93% 19.78%
Return on Assets (ROA)
3.62% 3.38% 3.17% 0.74% 3.96% -0.93% 0.53% 0.75% - 5.39% 13.91%
Return on Common Equity (ROCE)
12.71% 12.06% 12.06% 48.00% 12.77% 0.81% 3.88% 4.80% - 14.10% 31.54%
Return on Equity Simple (ROE_SIMPLE)
0.00% 12.02% 8.48% 5.92% 0.00% 4.06% 0.00% 0.00% - 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
147 131 147 699 162 20 59 76 120 177 432
NOPAT Margin
9.09% 9.22% 10.11% 49.15% 11.46% 1.44% 3.99% 4.88% - 11.41% 25.08%
Net Nonoperating Expense Percent (NNEP)
3.51% 2.26% 3.23% 34.96% 3.16% 2.41% 2.53% 3.22% - 2.55% 3.10%
Return On Investment Capital (ROIC_SIMPLE)
1.61% - - - 1.91% 0.24% 0.68% 0.86% 1.37% 1.95% 4.67%
Cost of Revenue to Revenue
72.96% 78.62% 77.54% 77.95% 76.46% 77.45% 76.65% 75.25% - 73.89% 70.80%
SG&A Expenses to Revenue
8.22% 9.80% 8.91% 8.14% 7.58% 8.80% 9.32% 8.93% - 9.61% 8.76%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Operating Expenses to Revenue
17.20% 11.72% 12.26% 17.83% 14.91% 20.49% 18.23% 20.16% - 11.49% -3.01%
Earnings before Interest and Taxes (EBIT)
161 146 148 65 130 30 71 73 99 227 554
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
301 275 274 190 260 156 193 198 240 359 685
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.73 1.62 1.32 1.32 1.22 1.13 1.31 1.08 - 2.10 1.71
Price to Tangible Book Value (P/TBV)
7.61 7.15 5.59 5.37 4.60 4.32 4.88 3.88 - 6.59 4.81
Price to Revenue (P/Rev)
1.17 1.16 0.96 1.02 0.93 0.88 1.06 0.87 - 1.63 1.37
Price to Earnings (P/E)
12.28 13.66 15.89 22.96 19.08 29.22 57.22 47.13 - 45.92 15.03
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Earnings Yield
8.15% 7.32% 6.29% 4.35% 5.24% 3.42% 1.75% 2.12% - 2.18% 6.66%
Enterprise Value to Invested Capital (EV/IC)
1.50 1.43 1.22 1.23 1.15 1.09 1.22 1.06 - 1.86 1.60
Enterprise Value to Revenue (EV/Rev)
1.49 1.47 1.28 1.33 1.24 1.20 1.37 1.17 - 1.88 1.56
Enterprise Value to EBITDA (EV/EBITDA)
6.81 6.88 6.73 7.55 7.08 7.72 9.78 8.46 - 11.97 6.90
Enterprise Value to EBIT (EV/EBIT)
10.36 11.07 12.24 15.08 14.45 18.17 26.37 22.42 - 25.24 10.73
Enterprise Value to NOPAT (EV/NOPAT)
11.58 12.12 12.41 15.23 13.08 14.34 17.58 18.15 - 28.45 13.18
Enterprise Value to Operating Cash Flow (EV/OCF)
11.22 9.69 8.63 8.70 8.43 8.23 9.48 8.83 - 12.31 7.57
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 13.50 8.56 10.95 6.13 7.80 17.59 20.70 - 45.81 13.18
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.94 0.95 0.97 0.92 0.91 0.86 0.85 0.86 - 0.83 0.74
Long-Term Debt to Equity
0.93 0.93 0.95 0.89 0.88 0.84 0.84 0.84 - 0.82 0.73
Financial Leverage
0.39 0.49 0.45 0.43 0.41 0.39 0.38 0.36 - 0.33 0.28
Leverage Ratio
2.36 2.48 2.40 2.35 2.31 2.28 2.26 2.24 - 2.18 2.13
Compound Leverage Factor
1.38 1.45 1.33 0.06 1.39 -1.87 0.59 0.60 - 1.69 1.92
Debt to Total Capital
48.54% 48.81% 49.26% 47.82% 47.52% 46.37% 45.89% 46.25% - 45.49% 42.66%
Short-Term Debt to Total Capital
0.67% 1.13% 1.03% 1.29% 1.56% 1.38% 0.60% 0.87% - 0.83% 1.05%
Long-Term Debt to Total Capital
47.87% 47.69% 48.23% 46.53% 45.95% 44.99% 45.30% 45.38% - 44.66% 41.61%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.97% 0.98% 0.91% 0.93% 1.02% 1.03% 0.92% 0.90% - 0.75% 0.65%
Common Equity to Total Capital
50.49% 50.20% 49.83% 51.25% 51.47% 52.60% 53.19% 52.85% - 53.76% 56.69%
Debt to EBITDA
2.99 3.25 3.80 4.08 4.05 4.46 4.99 5.08 - 4.16 2.66
Net Debt to EBITDA
1.38 1.41 1.59 1.69 1.67 1.92 2.12 2.07 - 1.56 0.80
Long-Term Debt to EBITDA
2.95 3.18 3.72 3.97 3.91 4.33 4.92 4.99 - 4.09 2.60
Debt to NOPAT
5.08 5.73 7.01 8.24 7.47 8.29 8.97 10.90 - 9.89 5.09
Net Debt to NOPAT
2.35 2.49 2.94 3.42 3.08 3.57 3.82 4.44 - 3.70 1.52
Long-Term Debt to NOPAT
5.01 5.60 6.87 8.02 7.23 8.04 8.85 10.70 - 9.71 4.96
Altman Z-Score
1.98 1.90 1.78 1.75 1.78 1.73 1.83 1.71 - 2.37 2.37
Noncontrolling Interest Sharing Ratio
2.05% 2.03% 1.82% 1.86% 1.91% 1.92% 1.75% 1.74% - 1.64% 1.40%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.86 1.67 1.57 1.41 1.38 1.40 1.50 1.49 - 1.58 1.56
Quick Ratio
0.93 0.80 0.73 0.65 0.64 0.66 0.71 0.71 - 0.72 0.76
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-1,368 51 430 900 776 416 59 30 -67 19 432
Operating Cash Flow to CapEx
124.04% 281.43% 149.58% 407.19% 210.55% 395.31% 205.47% 248.98% - 161.39% 414.04%
Free Cash Flow to Firm to Interest Expense
-19.99 0.81 6.21 13.46 14.13 7.18 1.07 0.52 - 0.35 7.79
Operating Cash Flow to Interest Expense
3.17 4.20 2.12 4.11 2.81 4.29 2.66 3.94 - 2.83 9.61
Operating Cash Flow Less CapEx to Interest Expense
0.61 2.71 0.70 3.10 1.48 3.21 1.36 2.36 - 1.08 7.29
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.67 0.59 0.57 0.55 0.54 0.54 0.55 0.56 - 0.61 0.62
Accounts Receivable Turnover
9.21 9.33 9.24 9.01 8.23 9.30 9.57 9.76 - 10.22 10.00
Inventory Turnover
7.18 6.45 6.42 6.29 6.64 6.84 7.13 7.20 - 8.08 7.97
Fixed Asset Turnover
2.52 2.28 2.18 2.09 2.02 2.01 2.03 2.07 - 2.28 2.33
Accounts Payable Turnover
11.45 12.59 12.01 12.47 11.46 12.69 12.30 12.64 - 13.45 12.39
Days Sales Outstanding (DSO)
39.65 39.10 39.51 40.51 44.35 39.26 38.16 37.41 - 35.73 36.50
Days Inventory Outstanding (DIO)
50.83 56.56 56.88 58.02 54.93 53.33 51.18 50.68 - 45.17 45.80
Days Payable Outstanding (DPO)
31.87 28.99 30.40 29.26 31.85 28.76 29.69 28.87 - 27.14 29.47
Cash Conversion Cycle (CCC)
58.61 66.67 65.98 69.27 67.43 63.83 59.65 59.22 - 53.76 52.83
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
6,742 6,621 6,389 6,394 6,129 6,224 6,389 6,441 6,316 6,382 6,389
Invested Capital Turnover
1.13 0.98 0.94 0.91 0.89 0.88 0.89 0.91 - 1.00 1.03
Increase / (Decrease) in Invested Capital
1,515 80 -283 -201 -613 -397 0.23 46 187 158 -0.09
Enterprise Value (EV)
10,088 9,448 7,800 7,848 7,073 6,788 7,805 6,831 - 11,865 10,228
Market Capitalization
7,951 7,420 5,872 6,005 5,322 5,012 6,029 5,079 - 10,254 8,984
Book Value per Share
$28.87 $28.75 $27.92 $28.62 $27.53 $28.00 $29.17 $29.64 $29.95 $30.74 $33.01
Tangible Book Value per Share
$6.55 $6.49 $6.57 $7.03 $7.27 $7.31 $7.82 $8.27 $9.06 $9.81 $11.76
Total Capital
9,121 9,149 8,952 8,881 8,506 8,457 8,673 8,873 8,747 9,070 9,254
Total Debt
4,427 4,466 4,409 4,246 4,042 3,922 3,980 4,104 3,937 4,126 3,948
Total Long-Term Debt
4,366 4,363 4,317 4,132 3,909 3,805 3,929 4,027 3,862 4,051 3,851
Net Debt
2,049 1,938 1,846 1,760 1,665 1,688 1,696 1,672 1,625 1,543 1,183
Capital Expenditures (CapEx)
175 94 98 67 73 63 71 90 156 95 129
Debt-free, Cash-free Net Working Capital (DFCFNWC)
791 606 489 395 415 414 428 463 489 543 552
Debt-free Net Working Capital (DFNWC)
918 755 637 549 529 536 550 570 594 682 731
Net Working Capital (NWC)
858 652 544 434 396 419 499 493 519 606 634
Net Nonoperating Expense (NNE)
59 49 66 680 59 44 45 55 61 40 43
Net Nonoperating Obligations (NNO)
2,049 1,938 1,846 1,760 1,665 1,688 1,696 1,672 1,507 1,438 1,083
Total Depreciation and Amortization (D&A)
139 129 126 125 130 125 123 125 141 132 131
Debt-free, Cash-free Net Working Capital to Revenue
11.66% 9.44% 7.99% 6.67% 7.27% 7.30% 7.51% 7.92% - 8.62% 8.44%
Debt-free Net Working Capital to Revenue
13.53% 11.77% 10.41% 9.28% 9.26% 9.44% 9.65% 9.75% - 10.81% 11.16%
Net Working Capital to Revenue
12.63% 10.16% 8.90% 7.35% 6.93% 7.38% 8.74% 8.43% - 9.62% 9.69%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.53 $0.51 $0.49 $0.11 $0.64 ($0.16) $0.08 $0.12 $0.36 $0.85 $2.44
Adjusted Weighted Average Basic Shares Outstanding
159.61M 159.78M 159.02M 159.05M 158.87M 158.16M 158.19M 158.19M 158.60M 158.93M 157.80M
Adjusted Diluted Earnings per Share
$0.53 $0.50 $0.49 $0.11 $0.63 ($0.16) $0.08 $0.12 $0.35 $0.83 $2.41
Adjusted Weighted Average Diluted Shares Outstanding
159.61M 159.78M 159.02M 159.05M 158.87M 158.16M 158.19M 158.19M 158.60M 158.93M 157.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
159.61M 159.78M 159.02M 159.05M 158.87M 158.16M 158.19M 158.19M 158.60M 158.93M 157.80M
Normalized Net Operating Profit after Tax (NOPAT)
157 110 116 54 85 25 72 54 112 181 446
Normalized NOPAT Margin
9.76% 7.75% 7.95% 3.78% 6.03% 1.80% 4.87% 3.47% - 11.69% 25.85%
Pre Tax Income Margin
5.85% 6.02% 5.64% 0.12% 5.52% -1.81% 1.24% 1.27% - 11.33% 29.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.36 2.32 2.14 0.97 2.37 0.52 1.29 1.29 - 4.19 9.97
NOPAT to Interest Expense
2.14 2.08 2.13 10.46 2.96 0.34 1.08 1.34 - 3.27 7.79
EBIT Less CapEx to Interest Expense
-0.20 0.83 0.73 -0.04 1.04 -0.56 -0.01 -0.29 - 2.44 7.65
NOPAT Less CapEx to Interest Expense
-0.41 0.59 0.71 9.45 1.62 -0.74 -0.22 -0.24 - 1.52 5.47
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
1.38% 0.00% 1.67% 3.40% 3.77% 0.00% 7.71% 11.19% - 0.00% 1.31%
Augmented Payout Ratio
9.39% 1.66% 9.38% 14.24% 15.76% 38.21% 42.78% 45.67% - 0.00% 13.42%

Financials Breakdown Chart

Key Financial Trends

Darling Ingredients (NYSE: DAR) showed a mixed but generally improving operating picture in Q1 2026, with strong profitability and cash generation offset by a still-heavy balance sheet and continued reliance on financing activity.

  • Q1 2026 revenue rose to $1.55 billion, up from $1.48 billion in Q2 2025 and roughly in line with recent quarters, showing the top line remains resilient.
  • Gross profit improved to $404.9 million, and operating income came in at $226.8 million, both above the prior quarter and well ahead of most 2024 comparisons.
  • Net income attributable to common shareholders reached $134.3 million in Q1 2026, a solid rebound from $56.9 million in Q4 2025 and $19.4 million in Q3 2025.
  • Operating cash flow was strong at $153.0 million, while the company still generated $24.7 million in net cash growth for the quarter despite investment spending.
  • DAR continued to produce healthy cash from operations relative to reported earnings, helped by $130.9 million of depreciation and other non-cash items.
  • Total equity increased to $4.88 billion, up from $4.69 billion at Q3 2025, reflecting retained earnings growth.
  • Shares outstanding remained essentially flat at about 159 million, indicating limited dilution in the latest quarter.
  • The company is still active on the M&A front, with $201.6 million spent on acquisitions in Q1 2026 after smaller deals in prior quarters.
  • Capital spending remained meaningful at $94.8 million, suggesting management is continuing to invest in the asset base.
  • Interest expense stayed elevated at $54.1 million, which continues to pressure pre-tax earnings despite strong operating profit.
  • Darling Ingredients is still highly leveraged, with $4.05 billion in long-term debt and $4.13 billion in total debt including short-term borrowings.
  • Financing activity in Q1 2026 included $339.8 million of debt issuance and $134.6 million of debt repayment, showing ongoing refinancing dependence.
  • The balance sheet carries a large amount of goodwill and intangibles, including $2.49 billion of goodwill and $832 million of intangibles, which can become a risk if operating conditions weaken.
  • Accumulated other comprehensive loss remained substantial at -$322.4 million, reflecting lingering balance-sheet pressure.

Bottom line: DAR appears to be recovering operationally, with better margins, stronger earnings, and solid operating cash flow in Q1 2026. However, investors should keep an eye on leverage, refinancing needs, and acquisition spending, since those remain the main financial risks.

08/20/26 10:34 AM ETAI Generated. May Contain Errors.

Darling Ingredients Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Darling Ingredients' fiscal year ends in January. Their fiscal year 2026 ended on January 3, 2026.

Darling Ingredients' net income appears to be on an upward trend, with a most recent value of $70.39 million in 2025, falling from $85.28 million in 2015. The previous period was $285.85 million in 2024. Find out what analysts predict for Darling Ingredients in the coming months.

Darling Ingredients' total operating income in 2025 was $273.44 million, based on the following breakdown:
  • Total Gross Profit: $1.47 billion
  • Total Operating Expenses: $1.20 billion

Over the last 10 years, Darling Ingredients' total revenue changed from $3.39 billion in 2015 to $6.14 billion in 2025, a change of 80.9%.

Darling Ingredients' total liabilities were at $5.49 billion at the end of 2025, a 2.1% decrease from 2024, and a 97.0% increase since 2015.

In the past 10 years, Darling Ingredients' cash and equivalents has ranged from $68.91 million in 2021 to $156.88 million in 2015, and is currently $88.67 million as of their latest financial filing in 2025.

Over the last 10 years, Darling Ingredients' book value per share changed from 11.36 in 2015 to 29.95 in 2025, a change of 163.7%.



Financial statements for NYSE:DAR last updated on 8/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners